These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 37007005)

  • 21. Surface engineering of iron oxide nanoparticles for targeted cancer therapy.
    Kievit FM; Zhang M
    Acc Chem Res; 2011 Oct; 44(10):853-62. PubMed ID: 21528865
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Zeolites for theranostic applications.
    Khodadadi Yazdi M; Zarrintaj P; Hosseiniamoli H; Mashhadzadeh AH; Saeb MR; Ramsey JD; Ganjali MR; Mozafari M
    J Mater Chem B; 2020 Jul; 8(28):5992-6012. PubMed ID: 32602516
    [TBL] [Abstract][Full Text] [Related]  

  • 23. IGF1 Receptor Targeted Theranostic Nanoparticles for Targeted and Image-Guided Therapy of Pancreatic Cancer.
    Zhou H; Qian W; Uckun FM; Wang L; Wang YA; Chen H; Kooby D; Yu Q; Lipowska M; Staley CA; Mao H; Yang L
    ACS Nano; 2015 Aug; 9(8):7976-91. PubMed ID: 26242412
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Multifunctional hybrid nanoconstructs facilitate intracellular localization of doxorubicin and genistein to enhance apoptotic and anti-angiogenic efficacy in breast adenocarcinoma.
    Shukla RP; Dewangan J; Urandur S; Banala VT; Diwedi M; Sharma S; Agrawal S; Rath SK; Trivedi R; Mishra PR
    Biomater Sci; 2020 Mar; 8(5):1298-1315. PubMed ID: 31903460
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Design, preparation, and in vitro characterization of a trimodally-targeted nanomagnetic onco-theranostic system for cancer diagnosis and therapy.
    Zarrin A; Sadighian S; Rostamizadeh K; Firuzi O; Hamidi M; Mohammadi-Samani S; Miri R
    Int J Pharm; 2016 Mar; 500(1-2):62-76. PubMed ID: 26721723
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Theranostic Applications of Nanomaterials in Alzheimer's Disease: A Multifunctional Approach.
    Tripathi P; Shukla P; Bieberich E
    Curr Pharm Des; 2022; 28(2):116-132. PubMed ID: 34809540
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Magnetoliposomes: recent advances in the field of controlled drug delivery.
    Veloso SRS; Andrade RGD; Castanheira EMS
    Expert Opin Drug Deliv; 2021 Oct; 18(10):1323-1334. PubMed ID: 33836636
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cancer theranostic platforms based on injectable polymer hydrogels.
    Wang F; Chen J; Liu J; Zeng H
    Biomater Sci; 2021 May; 9(10):3543-3575. PubMed ID: 33634800
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A positron emission tomography image-guidable unimolecular micelle nanoplatform for cancer theranostic applications.
    Yang J; Lu W; Xiao J; Zong Q; Xu H; Yin Y; Hong H; Xu W
    Acta Biomater; 2018 Oct; 79():306-316. PubMed ID: 30172067
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Multifunctional Nanoparticles in Precise Cancer Treatment: Considerations in Design and Functionalization of Nanocarriers.
    Lu L; Kang S; Sun C; Sun C; Guo Z; Li J; Zhang T; Luo X; Liu B
    Curr Top Med Chem; 2020; 20(27):2427-2441. PubMed ID: 32842941
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An overview of nanoscale radionuclides and radiolabeled nanomaterials commonly used for nuclear molecular imaging and therapeutic functions.
    Farzin L; Sheibani S; Moassesi ME; Shamsipur M
    J Biomed Mater Res A; 2019 Jan; 107(1):251-285. PubMed ID: 30358098
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fibrin nanoconstructs: a novel processing method and their use as controlled delivery agents.
    Praveen G; Sreerekha PR; Menon D; Nair SV; Chennazhi KP
    Nanotechnology; 2012 Mar; 23(9):095102. PubMed ID: 22322015
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Modulating Phagocytic Cell Sequestration by Tailoring Nanoconstruct Softness.
    Palomba R; Palange AL; Rizzuti IF; Ferreira M; Cervadoro A; Barbato MG; Canale C; Decuzzi P
    ACS Nano; 2018 Feb; 12(2):1433-1444. PubMed ID: 29314819
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rationally designed nanovehicles to overcome cancer chemoresistance.
    Livney YD; Assaraf YG
    Adv Drug Deliv Rev; 2013 Nov; 65(13-14):1716-30. PubMed ID: 23954781
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Theranostic nanomedicine.
    Lammers T; Aime S; Hennink WE; Storm G; Kiessling F
    Acc Chem Res; 2011 Oct; 44(10):1029-38. PubMed ID: 21545096
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Biodegradable dendritic Boltorn™ nanoconstructs: A promising avenue for cancer theranostics.
    Korake S; Shaikh A; Salve R; Gajbhiye KR; Gajbhiye V; Pawar A
    Int J Pharm; 2021 Feb; 594():120177. PubMed ID: 33333177
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vitro and in vivo evaluation of anti-nucleolin-targeted magnetic PLGA nanoparticles loaded with doxorubicin as a theranostic agent for enhanced targeted cancer imaging and therapy.
    Mosafer J; Abnous K; Tafaghodi M; Mokhtarzadeh A; Ramezani M
    Eur J Pharm Biopharm; 2017 Apr; 113():60-74. PubMed ID: 28012991
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Biomimetic Targeted Theranostic Nanoparticles for Breast Cancer Treatment.
    Marshall SK; Angsantikul P; Pang Z; Nasongkla N; Hussen RSD; Thamphiwatana SD
    Molecules; 2022 Oct; 27(19):. PubMed ID: 36235009
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Functionalized milk-protein-coated magnetic nanoparticles for MRI-monitored targeted therapy of pancreatic cancer.
    Huang J; Qian W; Wang L; Wu H; Zhou H; Wang AY; Chen H; Yang L; Mao H
    Int J Nanomedicine; 2016; 11():3087-99. PubMed ID: 27462153
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Biomimetic nanoarchitecturing: A disguised attack on cancer cells.
    Jha A; Nikam AN; Kulkarni S; Mutalik SP; Pandey A; Hegde M; Rao BSS; Mutalik S
    J Control Release; 2021 Jan; 329():413-433. PubMed ID: 33301837
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.